Organization | The Government Pharmaceutical Organization

The Government Pharmaceutical Organization Report issue

Government Phase 2 Phase 3

Founded: Bangkok Thailand (1966)

Organization Overview

First Clinical Trial

2007

NCT00477126

First Marketed Drug

None

First NDA Approval

None

Last Known Activity

2021

Timeline

NOW

Now

Alternative names

The Government Pharmaceutical Organization

Active Ingredients

Drugs in Phase 3 Trials (1)

inactivated influenza vaccine (3 trials)

Drugs in Phase 2 Trials (6)

influenza vlp vaccine (1 trial)

lopinavir (Kaletra) (1 trial)

ndv-hxp-s (1 trial)

ritonavir (Norvir) (3 trials)

saquinavir (invirase) (1 trial)

tivantinib (1 trial)

Drugs in Other Trials (3)

enalapril (vasotec) (1 trial)

simvastatin (zocor) (1 trial)

sitagliptin (januvia) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)

HIV Infections (Phase 2)

Influenza, Human (Phase 3)

Influenza in Birds (Phase 2)

Overview

Highest Phase: Phase 3
# of Trials: 10
# of Trial APIs: 10